Company Updates
January 8, 2021

Insights about Moonfare’s latest top North-American fund addition

Nicolas Cole

Moonfare’s recent investment strategy opens a door to a key industry nowadays, expected to reach $727bn by 2025 – biotechnology.

The fund manager holds a strong track record of investing in the fastest growing generation of healthcare companies, operating at the intersection of tech and biotech.

Insights about Moonfare’s latest top North-American fund addition

To learn more about opportunities to invest in private equity funds, please contact our team or your dedicated relationship manager. Please note that for regulatory reasons, Moonfare is only permitted to share specific investment opportunities with qualified registered users.

Nicolas Cole

Join the Moonfare Platform

Create an Account

Already have an account? Sign in